Miniantibody

Known as: MiniAb 
A peptide resembling the complementary determining region of an antibody and retaining its specificity. These are being studied for therapeutic and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
02419932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
BACKGROUND Phage display antibody libraries have been made from the lymphocytes of patients suffering from autoimmune diseases in… (More)
  • table 1
Is this relevant?
2006
2006
A major goal in antibody design for cancer therapy is to tailor the pharmacokinetic properties of the molecule according to… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
We monitored the number of intravascular platelet-leukocyte aggregates (PLAs) and thrombotic occlusions (TOs) by intravascular… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 4
  • figure 3
Is this relevant?
2000
2000
An HIV-1-specific miniantibody, a peptide representing the third heavy chain complementarity-determining region (CDR) of an HIV… (More)
Is this relevant?
1998
1998
Bispecific antibodies extend the capabilities of nature and might be applied in immunotherapy and biotechnology. By fusing the… (More)
Is this relevant?
1998
1998
The paper describes the synthesis of the phosphorylcholine-binding miniantibody McPC603scFvDhl x in cell-wall-less L-form strains… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1996
1996
Several antibody-dependent mechanisms have been postulated to mediate neutralization of different animal viruses, including… (More)
Is this relevant?
1995
1995
We have designed tetravelent miniantibodies assembling in the periplasm of Escherichia coli. They are based on single-chain Fv… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
1993
1993
The combination of single-chain Fv-fragments (scFv) with a C-terminal, flexible linking region followed by a designed or natural… (More)
Is this relevant?
1993
1993
A complementarity-determining region (CDR) of the mouse monoclonal antibody (mAb) F58 was constructed with specificity to a… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?